Syndax Pharmaceuticals Inc
- Stock
- Ticker SNDX
- ISIN US87164F1057
- Nasdaq
Performance, volatility and drawdowns of Syndax Pharmaceuticals Inc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $8,441. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −75.8% in 12/2018, measured from the peak in 03/2017. It took 38 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 7.7 | 20 | 38 | 46 | 69 | 65 | 73 | 83 |
| Operating income | -96 | -84 | -69 | -57 | -63 | -34 | -40 | -42 |
| EBITDA | – | -84 | -69 | -54 | -60 | -30 | -35 | -36 |
| Net income | -94 | -85 | -72 | -61 | -68 | -43 | -49 | -49 |
| Earnings per share | -1.09 | -0.98 | -0.83 | -0.70 | -0.78 | -0.48 | -0.55 | -0.55 |
| Balance sheet | ||||||||
| Total assets | 725 | 641 | 596 | 552 | 530 | 473 | 704 | 693 |
| Liabilities | 437 | 426 | 439 | 436 | 465 | 431 | 689 | 710 |
| Equity | 288 | 215 | 157 | 115 | 65 | 42 | 15 | -17 |
| Cash | 154 | 154 | 109 | 117 | 135 | 131 | 336 | 136 |
| Cash flow | ||||||||
| Operating cash flow | -57 | -95 | -88 | -71 | -69 | -50 | -30 | -27 |
| Free cash flow | -57 | -95 | -88 | -71 | -69 | -50 | -30 | -27 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2020 at +153.3%, weakest 2018 at −49.2%. 5 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 2 Nov 2026 | −$0.55 |
| 4 Aug 2026 | −$0.55 |
| 30 Apr 2026 | −$0.48 |
| 26 Feb 2026 | −$0.78 |
| 3 Nov 2025 | −$0.70 |
| 4 Aug 2025 | −$0.83 |
| 5 May 2025 | −$0.98 |
| 3 Mar 2025 | −$1.09 |
| 5 Nov 2024 | −$0.98 |
| 1 Aug 2024 | −$0.80 |
| 8 May 2024 | −$0.85 |
| 27 Feb 2024 | −$1.01 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €711m
- Market cap in trading currency
- $785m
- Enterprise value
- $708m
- P/E
- –
- P/S
- 2.71
- P/B
- –
- EV/Sales
- 2.44
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -22.6%
Results (last four quarters)
- Revenue
- $290m
- Gross profit
- –
- EBITDA
- −$161m
- Net income
- −$209m
- Earnings per share
- −$2.36
- Revenue per share
- $3.22
- Revenue growth
- +81.6%
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- -61.7%
- Net margin
- -72.3%
- Return on equity
- –
- Return on assets
- -30.2%
Balance sheet and cash flow
- Cash
- $427m
- Cash per share
- $4.75
- Financial debt
- $350m
- Debt/equity %
- –
- Current ratio
- 4.69
- Book value per share
- −$0.19
- Operating cash flow
- −$177m
- Free cash flow
- −$177m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 90.0m
- Volume
- 2.18m
- Avg. volume 3 months
- 2.53m
- Relative volume
- 0.8
Price and technicals
- Price
- $8.72
- 1 day
- −4.5%
- 52-week high
- $25.15
- 52-week low
- $8.56
- Distance to 52-week high
- −65.3%
- Distance to 52-week low
- +1.9%
- Distance to 50-day line
- −38.7%
- Distance to 200-day line
- −55.1%
- RSI (14)
- 28
- Volatility 1M
- 127.0%
Performance
- 1 week
- −7.7%
- 1 month
- −35.7%
- 3 months
- −55.4%
- 6 months
- −56.3%
- YTD
- −58.5%
- 1 year
- −47.8%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has SNDX performed since 11/2016?
$10,000 grew to $8,441 by 20 Nov 2026, which is −1.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is SNDX?
Volatility was 66.6% per year, measured on monthly returns. The largest decline from a peak was −75.8%, with the low in 12/2018.
How does SNDX compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, SNDX returned −1.7% at 66.6%. The correlation of monthly returns was 0.28; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.